Published in AIDS Weekly, September 13th, 1999
"We have carried out three clinical trials in humans," reported A. Gringeri of IRCCS Maggiore Hospital, Milan, Italy, in a presentation to the 1999 Meeting of the Institute of Human Virology, held August 28-September 2 in Baltimore, Maryland.
Tat toxoid is being developed and tested in a collaboration between Robert Gallo and colleagues of the Institute of Human Virology and Daniel Zagury, Gringeri, and colleagues at IRCCS. C. David Pauza...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.